A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy

Journal of Molecular Endocrinology

Volumn 46, Issue 3, 2011, Pages 155-163

  Kumar, Seema ^a   Nadeem, Sarah ^a   Stan, Marius N ^a   Coenen, Michael ^a   Bahn, Rebecca S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADENYLATE CYCLASE; ADIPONECTIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIC AMP; LEPTIN; MONOLCLONAL ANTIBODY M22; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROADIPOCYTE; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOGENESIS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELLS, CULTURED; CYCLIC AMP; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAVES OPHTHALMOPATHY; HUMANS; ORBIT; PHOSPHATIDYLINOSITOL 3-KINASES; RECEPTORS, THYROTROPIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYROTROPIN;

EID: 79959508641     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-11-0006     Document Type: Article

References (31)

1. Bahn RS 2010 Mechanisms of disease: Graves' ophthalmopathy. New England Journal of Medicine 362 726-738. (doi:10.1056/ NEJMra0905750)
2. Bahn RS, Gorman CA, Johnson CM & Smith TJ 1989 Presence of antibodies in the sera of patients with Graves' disease recognizing a 23 kilodalton fibroblast protein. Journal of Clinical Endocrinology and Metabolism 69 622-628. (doi:10.1210/jcem-69-3-622)
3. Bahn RS, Dutton CM, Natt N, Joba W, Spitzweg C & Heufelder AE 1998 Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 83 998-1002. (doi:10.1210/jc.83.3.998)
4. Crisp M, Starkey K, Lane C, Ham J & Ludgate M 2000 Adipogenesis in thyroid eye disease. Investigative Ophthalmology and Visual Science 41 3249-3255.
5. Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, Heckmann C, Esser J & Morgenthaler NG 2006 Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. Journal of Clinical Endocrinology and Metabolism 91 3464-3470. (doi:10.1210/jc.2005-2813)
6. Engelman JA, Berg AH, Lewis RY, Lin A, Lisanti MP & Scherer PE 1999 Constitutively active mitogen-activated protein kinase kinase 6 (MKK6) or salicylate induces spontaneous 3T3-L1 adipogenesis. Journal of Biological Chemistry 274 35630-35638. (doi:10.1074/jbc. 274.50.35630)
7. Feliciello A, Porcellini A, Ciullo I, Bonavolonta G, Avvedimento EV & Fenzi G 1993 Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet 342 337-338. (doi:10.1016/0140-6736(93)91475-2)
8. Forbes G, Gorman CA, Brennan MD, Gehring DG, Ilstrup DM & Earnest Ft 1986 Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle. AJNR. American Journal of Neuroradiology 7 651-656.
9. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM & Prummel MF 2000 Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clinical Endocrinology 52 267-271. (doi:10.1046/j.1365-2265.2000.00959.x)
10. Gregiore F, Smas C & Sul H 1998 Understanding adipocyte differentiation. Physiological Reviews 78 783-809.
11. Heufelder AE, Dutton CM, Sarkar G, Donovan KA & Bahn RS 1993 Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3 297-300. (doi:10.1089/thy.1993.3.297)
12. Kimura T, Van K, Golstein J, Fusco A, Dumont J & Roger P 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 22 631-656. (doi:10.1210/er.22.5.631)
13. Kohn A, Summers S, Birnbaum M & Roth R 1996 Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. Journal of Biological Chemistry 271 31372-31378. (doi:10.1074/jbc. 271.49.31372)
14. Kumar S, Coenen MJ, Scherer PE & Bahn RS 2004 Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 89 930-935. (doi:10.1210/jc.2003-031427)
15. Lu M & Lin RY 2008 TSH stimulates adipogenesis in mouse embryonic stem cells. Journal of Endocrinology 196 159-169. (doi:10.1677/JOE-07-0452)
16. Mengistu M, Lukes YG, Nagy EV, Burch HB, Carr FE, Lahiri S & Burman KD 1994 TSH receptor gene expression in retroocular fibroblasts. Journal of Endocrinological Investigation 17 437-441.
17. Morshad SA, Latif R & Davies TF 2009 Characterization of thyrotropin receptor antibody-induced signaling cascades. Endocrinology 150 519-529. (doi:10.1210/en.2008-0878)
18. Rapoport B, Chazenbalk GD, Jaume JC & McLachlan SM 1998 The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocrine Reviews 19 673-716. (doi:10.1210/er.19.6.673)
19. Rosen ED & MacDougald OA 2006 Adipocyte differentiation from the inside out. Nature Reviews. Molecular Cell Biology 7 885-896. (doi:10.1038/nrm2066)
20. Sanders J, Evans M, Premawaradhana L, Depraetere H, Jeffreys J, Richards T, Furmaniak J & Smith B 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362 126-128. (doi:10. 1016/S0140-6736(03)13866-4)
21. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LD, Chirgadze DY, Nunez Miguel R et al. 2004 Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14 560-570. (doi:10.1089/1050725041692918)
22. Smith TJ 2003 The putative role of fibroblasts in the pathogenesis of Graves' disease: evidence for the involvement of the insulin-like growth factor-1 receptor in fibroblast activation. Autoimmunity 36 409-415. (doi:10.1080/08916930310001603000)
23. Smith TJ & Hoa N 2004 Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. Journal of Clinical Endocrinology and Metabolism 89 5076-5080. (doi:10.1210/jc.2004-0716)
24. Smith TJ, Bahn RS & Gorman CA 1989 Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocrine Reviews 10 366-391. (doi:10.1210/edrv-10-3-366)
25. Valyasevi RW, Erickson DZ, Harteneck DA, Dutton CM, Heufelder AE, Jyonouchi SC & Bahn RS 1999 Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. Journal of Clinical Endocrinology and Metabolism 84 2557-2562. (doi:10.1210/jc.84.7.2557)
26. Wakelkamp IM, Bakker O, Baldeschi L, Wiersinga WM & Prummel MF 2003 TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clinical Endocrinology 58 280-287. (doi:10.1046/j.1365-2265.2003.01708.x)
27. Xu J & Liao K 2004 Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. Journal of Biological Chemistry 279 35914-35922. (doi:10.1074/jbc.M402297200)
28. Zaballos M, Garcia B & Santisteban P 2008 G beta gamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Molecular Endocrinology 22 1183-1199. (doi:10.1210/me.2007-0093)
29. Zhang L, Baker G, Janus D, Paddon CA, Fuhrer D & Ludgate M 2006 Biological effects of thyrotropin receptor activation on human orbital preadipocytes. Investigative Ophthalmology and Visual Science 47 5197-5203. (doi:10.1167/iovs.06-0596)
30. Zhang L, Paddon C, Lewis MD, Grennan-Jones F & Ludgate M 2009a Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis. Journal of Endocrinology 202 207-215. (doi:10.1677/JOE-09-0099)
31. Zhang LS, Greyner HJ, Mummert ME & Petroll WM 2009b Development of a hyaluronan bioconjugate for the topical treatment of melanoma. Journal of Dermatological Science 55 56-59. (doi:10.1016/j.jdermsci.2009.02.014)